Access Statistics for Simona Gamba

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit publicity and tax compliance: a quasi-natural experiment 0 0 0 65 0 0 12 147
COVID-19: $R_0$ is lower where outbreak is larger 0 0 0 12 0 0 10 58
COVID-19: R0 is lower where outbreak is larger 0 0 0 29 0 1 9 130
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 0 0 2 156 1 4 35 428
Is Tax Compliance a Social Norm? A Field Experiment 0 0 0 251 0 0 18 694
Lies have long legs. Cheating, public scrutiny and loyalty in teams 0 0 1 44 0 0 21 180
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 2 24 0 2 26 77
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 1 17 1 1 19 55
Optimizing Tax Administration Policies with Machine Learning 0 0 2 267 1 2 28 720
R&D and market size: who benefits from orphan drug regulation? 0 0 0 76 0 2 14 211
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 0 0 5 29 2 5 31 100
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 0 26 0 1 26 156
The Impact of Social Pressure on Tax Compliance: a Field Experiment 0 0 0 89 0 1 23 151
The Italian Blitz: a natural experiment on audit publicity and tax compliance 0 0 0 67 0 2 14 105
The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector 0 0 0 72 0 1 13 136
What exactly is public in a public good game? A lab-in-the-field experiment 0 0 3 159 0 2 18 384
When the two ends meet: an experiment on cooperation across the Italian North-South divide 0 0 0 95 1 3 31 185
Total Working Papers 0 0 16 1,478 6 27 348 3,917


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An experimental manipulation of divisibility in the public good game 0 0 1 1 0 0 7 7
Audit Publicity and Tax Compliance: A Natural Experiment 0 0 0 17 0 0 12 99
Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly 0 0 0 6 1 5 18 54
COVID-19: R0 is lower where outbreak is larger 0 0 0 3 0 0 16 31
Lies have long legs cheating, peer scrutiny and loyalty in teams 0 0 0 4 0 2 5 28
Machine learning and the optimization of prediction-based policies 0 1 3 8 1 4 25 44
R&D and market size: Who benefits from orphan drug legislation? 0 0 1 5 0 4 21 53
R&D investments, financing constraints, exporting and productivity 0 0 2 59 0 2 22 188
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis 0 2 4 4 0 2 15 15
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 1 20 1 1 18 132
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design 0 0 0 2 0 0 7 14
The impact of managed entry agreements on pharmaceutical prices 0 0 0 16 0 2 17 100
The impact of social pressure on tax compliance: A field experiment 0 1 3 29 0 1 13 140
When the two ends meet: an experiment on cooperation and social capital 1 1 2 8 3 3 24 54
Total Journal Articles 1 5 17 182 6 26 220 959


Statistics updated 2026-10-11